White Pine Capital LLC Lowers Stock Position in Transcat, Inc. (NASDAQ:TRNS)

White Pine Capital LLC lessened its holdings in Transcat, Inc. (NASDAQ:TRNS) by 3.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,689 shares of the scientific and technical instruments company’s stock after selling 296 shares during the quarter. White Pine Capital LLC owned 0.11% of Transcat worth $1,059,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. State Board of Administration of Florida Retirement System purchased a new stake in shares of Transcat during the 3rd quarter worth approximately $207,000. Arizona State Retirement System purchased a new stake in shares of Transcat during the 3rd quarter worth approximately $213,000. James Investment Research Inc. purchased a new stake in shares of Transcat during the 3rd quarter worth approximately $221,000. Quantbot Technologies LP boosted its stake in shares of Transcat by 118.2% during the 3rd quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock worth $232,000 after acquiring an additional 1,284 shares in the last quarter. Finally, Diversified Trust Co boosted its stake in shares of Transcat by 4.3% during the 4th quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock worth $266,000 after acquiring an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Trading Down 0.0 %

TRNS traded down $0.01 during trading on Friday, hitting $109.83. The company’s stock had a trading volume of 60,743 shares, compared to its average volume of 37,283. The firm’s 50 day moving average price is $108.73 and its 200-day moving average price is $102.61. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.37 and a quick ratio of 2.81. The stock has a market cap of $969.80 million, a PE ratio of 84.49 and a beta of 0.59. Transcat, Inc. has a twelve month low of $74.89 and a twelve month high of $116.19.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The business had revenue of $65.17 million during the quarter, compared to the consensus estimate of $63.36 million. Transcat had a return on equity of 9.32% and a net margin of 4.16%. On average, analysts expect that Transcat, Inc. will post 1.34 earnings per share for the current year.

Insider Transactions at Transcat

In other news, CEO Lee D. Rudow sold 5,000 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $111.30, for a total transaction of $556,500.00. Following the completion of the sale, the chief executive officer now directly owns 108,478 shares in the company, valued at approximately $12,073,601.40. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, CEO Lee D. Rudow sold 5,000 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $111.30, for a total transaction of $556,500.00. Following the completion of the sale, the chief executive officer now directly owns 108,478 shares of the company’s stock, valued at approximately $12,073,601.40. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Lee D. Rudow sold 2,373 shares of the company’s stock in a transaction on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the sale, the chief executive officer now directly owns 103,688 shares of the company’s stock, valued at $11,553,953.84. The disclosure for this sale can be found here. Insiders sold a total of 8,073 shares of company stock worth $900,023 in the last ninety days. Insiders own 4.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on TRNS. TheStreet upgraded Transcat from a “c+” rating to a “b” rating in a research report on Wednesday, January 31st. Oppenheimer reiterated an “outperform” rating and issued a $125.00 price target (up from $120.00) on shares of Transcat in a report on Thursday, April 18th. Finally, HC Wainwright reiterated a “buy” rating and issued a $124.00 price target on shares of Transcat in a report on Tuesday, April 16th.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.